Reaction

Haematocrit Increased reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,254 reports · 46 co-occurring drugs

As of the last recalculation, Haematocrit Increased appears in 2,254 FAERS reports alongside 46 co-occurring drug terms. The strongest observed disproportionality signal is RUXOLITINIB (PRR 52.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Ruxolitinib	343	52.0	52.2
Testosterone Cypionate	39	41.0	41.2
Hydroxyurea	69	31.1	31.2
Dimenhydrinate	32	28.1	28.2
Testosterone	64	26.0	26.1
Alemtuzumab	51	24.9	25.0
Cimetidine	22	21.3	21.3
Ciclesonide	24	16.4	16.5
Indapamide	28	14.6	14.6
Isosorbide Mononitrate	28	12.6	12.6
Empagliflozin	87	12.4	12.4
Insulin Glargine-Yfgn	27	11.5	11.5
Linagliptin	22	11.2	11.3
Eplerenone	14	10.2	10.2
Rosuvastatin Calcium	28	9.3	9.3
Hydroxyzine Hydrochloride	11	7.8	7.8
Hydroxyzine Hydrochloride Oral	11	7.8	7.8
Clozapine	101	7.7	7.7
0Xygen	37	7.0	7.0
Oxygen	37	7.0	7.0
Dutasteride	6	6.8	6.8
Ezetimibe	51	6.4	6.4
Thyroid, Porcine	7	6.1	6.1
Sildenafil Powder,	23	6.0	6.0
Erythropoietin	12	5.4	5.4
Tiotropium Bromide Inhalation Spray	6	5.0	5.0
Sildenafil	30	4.8	4.8
Memantine	7	4.7	4.7
Memantine Hydrochloride	7	4.7	4.7
Asfotase Alfa	5	4.6	4.6
Paliperidone	11	4.4	4.4
Somatropin	34	4.3	4.3
Fingolimod Hcl	38	4.1	4.1
Ticagrelor	14	4.1	4.1
Vilazodone Hydrochloride	4	4.0	4.0
Tolvaptan	6	3.8	3.8
Macitentan	28	3.8	3.8
Dabigatran Etexilate	31	3.7	3.7
Methoxy Polyethylene Glycol-Epoetin Beta	4	3.4	3.4
Axitinib	7	3.3	3.3
Treprostinil	44	3.3	3.3
Canagliflozin	8	2.5	2.5
Tafamidis	3	2.4	2.4
Romosozumab-Aqqg	3	2.0	2.0
Voxelotor	3	1.2	1.2
Tirzepatide	17	1.0	1.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.